Erythropoietin Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
The global erythropoietin drugs market size reached US$ 9.8 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 13.8 Billion by 2027, exhibiting a growth rate (CAGR) of 5.75% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Erythropoietin (EPO) is a hormone produced by kidneys to stimulate the production of red blood cells (RBCs). Its deficiency can lead to low hemoglobin levels and various medical conditions. As a result, there is a rise in the demand for EPO drugs, also known as EPO stimulating agents (ESAs), which are produced synthetically using recombinant deoxyribonucleic acid (DNA) technology. They are usually administered via the intramuscular route and released into the bloodstream to stimulate RBC production. At present, they are available in various types with different dosage schedules and modes of delivery. EPO drugs are generally given to patients undergoing chemotherapy, chronic renal failure, and antiviral drug therapy or at high risk for perioperative blood loss from surgical procedures.
Erythropoietin Drugs Market Trends:
Individuals who have anemia due to cancer, prematurity, and chronic kidney disease (CKD) are usually at the risk of low hemoglobin levels. This represents one of the key factors positively influencing the sales of EPO drugs worldwide. In addition, they are used to treat zidovudine among patients with human immunodeficiency virus (HIV) infection. Moreover, the rising need for surgical interventions on account of the growing aging population across the globe is catalyzing the use of EOP drugs to minimize allogeneic blood transfusions after surgical procedures. Furthermore, the escalating demand for minimally invasive (MI) procedures is bolstering the growth of the market. Apart from this, the increasing use of EPO drugs as a novel therapeutic agent in research settings is projected to expand their applications in treating various diseases. These diseases generally include spinal cord injury (SCI), depression, diabetes, acute kidney injury (AKI), recombinant therapy for patients with heart failure, and a neuroprotective agent in ischemic stroke.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global erythropoietin drugs market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on drug class, product type, application and end user.
Breakup by Drug Class:
Biologics
Biosimilars
Breakup by Product Type:
Epoetin-alfa
Epoetin-beta
Darbepoetin-alfa
Others
Breakup by Application:
Hematology
Kidney Disorder
Cancer
Others
Breakup by End User:
Hospitals
Homecare
Specialty Clinics
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Biocon Limited, Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche AG, Intas Pharmaceuticals Ltd., Johnson & Johnson, LG Chem Ltd., Pfizer Inc., Sun Pharmaceutical Industries Limited and Teva Pharmaceutical Industries Ltd.
Key Questions Answered in This Report:
How has the global erythropoietin drugs market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global erythropoietin drugs market?
What are the key regional markets?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the product type?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global erythropoietin drugs market and who are the key players?
What is the degree of competition in the industry?
Erythropoietin (EPO) is a hormone produced by kidneys to stimulate the production of red blood cells (RBCs). Its deficiency can lead to low hemoglobin levels and various medical conditions. As a result, there is a rise in the demand for EPO drugs, also known as EPO stimulating agents (ESAs), which are produced synthetically using recombinant deoxyribonucleic acid (DNA) technology. They are usually administered via the intramuscular route and released into the bloodstream to stimulate RBC production. At present, they are available in various types with different dosage schedules and modes of delivery. EPO drugs are generally given to patients undergoing chemotherapy, chronic renal failure, and antiviral drug therapy or at high risk for perioperative blood loss from surgical procedures.
Erythropoietin Drugs Market Trends:
Individuals who have anemia due to cancer, prematurity, and chronic kidney disease (CKD) are usually at the risk of low hemoglobin levels. This represents one of the key factors positively influencing the sales of EPO drugs worldwide. In addition, they are used to treat zidovudine among patients with human immunodeficiency virus (HIV) infection. Moreover, the rising need for surgical interventions on account of the growing aging population across the globe is catalyzing the use of EOP drugs to minimize allogeneic blood transfusions after surgical procedures. Furthermore, the escalating demand for minimally invasive (MI) procedures is bolstering the growth of the market. Apart from this, the increasing use of EPO drugs as a novel therapeutic agent in research settings is projected to expand their applications in treating various diseases. These diseases generally include spinal cord injury (SCI), depression, diabetes, acute kidney injury (AKI), recombinant therapy for patients with heart failure, and a neuroprotective agent in ischemic stroke.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global erythropoietin drugs market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on drug class, product type, application and end user.
Breakup by Drug Class:
Biologics
Biosimilars
Breakup by Product Type:
Epoetin-alfa
Epoetin-beta
Darbepoetin-alfa
Others
Breakup by Application:
Hematology
Kidney Disorder
Cancer
Others
Breakup by End User:
Hospitals
Homecare
Specialty Clinics
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Biocon Limited, Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche AG, Intas Pharmaceuticals Ltd., Johnson & Johnson, LG Chem Ltd., Pfizer Inc., Sun Pharmaceutical Industries Limited and Teva Pharmaceutical Industries Ltd.
Key Questions Answered in This Report:
How has the global erythropoietin drugs market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global erythropoietin drugs market?
What are the key regional markets?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the product type?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global erythropoietin drugs market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL ERYTHROPOIETIN DRUGS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY DRUG CLASS
6.1 Biologics
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Biosimilars
6.2.1 Market Trends
6.2.2 Market Forecast
7 MARKET BREAKUP BY PRODUCT TYPE
7.1 Epoetin-alfa
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Epoetin-beta
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Darbepoetin-alfa
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 MARKET BREAKUP BY APPLICATION
8.1 Hematology
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Kidney Disorder
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Cancer
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 MARKET BREAKUP BY END USER
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Homecare
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Specialty Clinics
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Amgen Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Biocon Limited
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Dr. Reddy’s Laboratories Ltd.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 F. Hoffmann-La Roche AG
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.5 Intas Pharmaceuticals Ltd.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Johnson & Johnson
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 LG Chem Ltd.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Pfizer Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Sun Pharmaceutical Industries Limited
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Teva Pharmaceutical Industries Ltd.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL ERYTHROPOIETIN DRUGS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY DRUG CLASS
6.1 Biologics
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Biosimilars
6.2.1 Market Trends
6.2.2 Market Forecast
7 MARKET BREAKUP BY PRODUCT TYPE
7.1 Epoetin-alfa
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Epoetin-beta
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Darbepoetin-alfa
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 MARKET BREAKUP BY APPLICATION
8.1 Hematology
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Kidney Disorder
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Cancer
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 MARKET BREAKUP BY END USER
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Homecare
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Specialty Clinics
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Amgen Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Biocon Limited
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Dr. Reddy’s Laboratories Ltd.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 F. Hoffmann-La Roche AG
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.5 Intas Pharmaceuticals Ltd.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Johnson & Johnson
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 LG Chem Ltd.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Pfizer Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Sun Pharmaceutical Industries Limited
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Teva Pharmaceutical Industries Ltd.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Erythropoietin Drugs Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Erythropoietin Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2022-2027
Table 3: Global: Erythropoietin Drugs Market Forecast: Breakup by Product Type (in Million US$), 2022-2027
Table 4: Global: Erythropoietin Drugs Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 5: Global: Erythropoietin Drugs Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 6: Global: Erythropoietin Drugs Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Erythropoietin Drugs Market: Competitive Structure
Table 8: Global: Erythropoietin Drugs Market: Key Players
Table 1: Global: Erythropoietin Drugs Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Erythropoietin Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2022-2027
Table 3: Global: Erythropoietin Drugs Market Forecast: Breakup by Product Type (in Million US$), 2022-2027
Table 4: Global: Erythropoietin Drugs Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 5: Global: Erythropoietin Drugs Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 6: Global: Erythropoietin Drugs Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Erythropoietin Drugs Market: Competitive Structure
Table 8: Global: Erythropoietin Drugs Market: Key Players
LIST OF FIGURES
Figure 1: Global: Erythropoietin Drugs Market: Major Drivers and Challenges
Figure 2: Global: Erythropoietin Drugs Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Erythropoietin Drugs Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Erythropoietin Drugs Market: Breakup by Drug Class (in %), 2021
Figure 5: Global: Erythropoietin Drugs Market: Breakup by Product Type (in %), 2021
Figure 6: Global: Erythropoietin Drugs Market: Breakup by Application (in %), 2021
Figure 7: Global: Erythropoietin Drugs Market: Breakup by End User (in %), 2021
Figure 8: Global: Erythropoietin Drugs Market: Breakup by Region (in %), 2021
Figure 9: Global: Erythropoietin Drugs (Biologics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Erythropoietin Drugs (Biologics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Erythropoietin Drugs (Biosimilars) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Erythropoietin Drugs (Biosimilars) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Erythropoietin Drugs (Epoetin-alfa) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Erythropoietin Drugs (Epoetin-alfa) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Erythropoietin Drugs (Epoetin-beta) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Erythropoietin Drugs (Epoetin-beta) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Erythropoietin Drugs (Darbepoetin-alfa) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Erythropoietin Drugs (Darbepoetin-alfa) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Erythropoietin Drugs (Other Product Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Erythropoietin Drugs (Other Product Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Erythropoietin Drugs (Hematology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Erythropoietin Drugs (Hematology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Erythropoietin Drugs (Kidney Disorder) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Erythropoietin Drugs (Kidney Disorder) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Erythropoietin Drugs (Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Erythropoietin Drugs (Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Erythropoietin Drugs (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Erythropoietin Drugs (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Erythropoietin Drugs (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Erythropoietin Drugs (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Erythropoietin Drugs (Homecare) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Erythropoietin Drugs (Homecare) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Erythropoietin Drugs (Specialty Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Erythropoietin Drugs (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Erythropoietin Drugs (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Erythropoietin Drugs (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: North America: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: North America: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: United States: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: United States: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Canada: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Canada: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Asia-Pacific: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Asia-Pacific: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: China: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: China: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Japan: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Japan: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: India: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: India: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: South Korea: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: South Korea: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Australia: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Australia: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Indonesia: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Indonesia: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Others: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Others: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Europe: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Europe: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Germany: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Germany: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: France: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: France: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: United Kingdom: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: United Kingdom: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Italy: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Italy: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Spain: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Spain: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Russia: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Russia: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Others: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Others: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Latin America: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Latin America: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Brazil: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Brazil: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Mexico: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Mexico: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Others: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Others: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Middle East and Africa: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Middle East and Africa: Erythropoietin Drugs Market: Breakup by Country (in %), 2021
Figure 85: Middle East and Africa: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 86: Global: Erythropoietin Drugs Industry: SWOT Analysis
Figure 87: Global: Erythropoietin Drugs Industry: Value Chain Analysis
Figure 88: Global: Erythropoietin Drugs Industry: Porter's Five Forces Analysis
Figure 1: Global: Erythropoietin Drugs Market: Major Drivers and Challenges
Figure 2: Global: Erythropoietin Drugs Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Erythropoietin Drugs Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Erythropoietin Drugs Market: Breakup by Drug Class (in %), 2021
Figure 5: Global: Erythropoietin Drugs Market: Breakup by Product Type (in %), 2021
Figure 6: Global: Erythropoietin Drugs Market: Breakup by Application (in %), 2021
Figure 7: Global: Erythropoietin Drugs Market: Breakup by End User (in %), 2021
Figure 8: Global: Erythropoietin Drugs Market: Breakup by Region (in %), 2021
Figure 9: Global: Erythropoietin Drugs (Biologics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Erythropoietin Drugs (Biologics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Erythropoietin Drugs (Biosimilars) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Erythropoietin Drugs (Biosimilars) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Erythropoietin Drugs (Epoetin-alfa) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Erythropoietin Drugs (Epoetin-alfa) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Erythropoietin Drugs (Epoetin-beta) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Erythropoietin Drugs (Epoetin-beta) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Erythropoietin Drugs (Darbepoetin-alfa) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Erythropoietin Drugs (Darbepoetin-alfa) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Erythropoietin Drugs (Other Product Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Erythropoietin Drugs (Other Product Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Erythropoietin Drugs (Hematology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Erythropoietin Drugs (Hematology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Erythropoietin Drugs (Kidney Disorder) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Erythropoietin Drugs (Kidney Disorder) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Erythropoietin Drugs (Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Erythropoietin Drugs (Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Erythropoietin Drugs (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Erythropoietin Drugs (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Erythropoietin Drugs (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Erythropoietin Drugs (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Erythropoietin Drugs (Homecare) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Erythropoietin Drugs (Homecare) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Erythropoietin Drugs (Specialty Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Erythropoietin Drugs (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Erythropoietin Drugs (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Erythropoietin Drugs (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: North America: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: North America: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: United States: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: United States: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Canada: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Canada: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Asia-Pacific: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Asia-Pacific: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: China: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: China: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Japan: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Japan: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: India: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: India: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: South Korea: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: South Korea: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Australia: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Australia: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Indonesia: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Indonesia: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Others: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Others: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Europe: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Europe: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Germany: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Germany: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: France: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: France: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: United Kingdom: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: United Kingdom: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Italy: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Italy: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Spain: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Spain: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Russia: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Russia: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Others: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Others: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Latin America: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Latin America: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Brazil: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Brazil: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Mexico: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Mexico: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Others: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Others: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Middle East and Africa: Erythropoietin Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Middle East and Africa: Erythropoietin Drugs Market: Breakup by Country (in %), 2021
Figure 85: Middle East and Africa: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 86: Global: Erythropoietin Drugs Industry: SWOT Analysis
Figure 87: Global: Erythropoietin Drugs Industry: Value Chain Analysis
Figure 88: Global: Erythropoietin Drugs Industry: Porter's Five Forces Analysis
